Cell lines and cell culture.
U87-MG, U251-MG and A172 were cultured in DMEM supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100 μg/ml). Human glioma-initiating cells (hGICs) were maintained in DMEM/Nutrient F-12 Ham (Sigma-Aldrich) supplemented with N-2 supplement (Life Technologies), L-glutamine (2 mM, Gibco), epidermal growth factor (20 ng/ml, Roche), basic fibroblast growth factor (20 ng/ml, PeproTech), leukemia inhibitory factor (10 ng/ml, Millipore), insulin sodium salt (1 ng/ml, Sigma-Aldrich) and heparin sodium salt (50 μg/ml, Sigma-Aldrich).
Western blotting. Cells grown on Matrigel were washed twice with ice-cold PBS and lysed with icecold cell lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EGTA, 1% Triton X-100) containing the Complete protease inhibitor cocktail (Roche) and the PhosSTOP phosphatase inhibitor cocktail (Roche). The lysates were cleared by centrifugation at 15,000 rpm for 30 min at 4°C, separated on SDS-PAGE and transferred to PVDF membrane. The membrane was blocked with 5% BSA for 30 min and incubated with primary antibodies overnight at 4°C. The membrane was incubated with HRP-conjugated appropriate secondary antibodies for 1 h. The immunoreactive bands were visualized by the ECL Prime Western Blotting Detection Reagent (GE Healthcare) and the VersaDoc
